These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature. Varettoni M; Defrancesco I; Diamanti L; Marchioni E; Farina LM; Pichiecchio A Mediterr J Hematol Infect Dis; 2017; 9(1):e2017061. PubMed ID: 29181138 [TBL] [Abstract][Full Text] [Related]
84. Successful Treatment of Bing-Neel Syndrome Accompanying Waldenström's Macroglobulinemia with R-MPV: A Case Report. Kikukawa Y; Yamamura-Fujimoto A; Endo S; Miyagawa E; Kawano Y; Ueno S; Mitsuya H; Hata H; Okuno Y J Clin Exp Hematop; 2015; 55(2):113-9. PubMed ID: 26490525 [TBL] [Abstract][Full Text] [Related]
85. Pathologic quiz case. A man with long-standing monoclonal gammopathy and new onset of confusion. Central nervous system involvement by Waldenström macroglobulinemia-Bing-Neel syndrome. Welch D; Whetsell WO; Weil RJ Arch Pathol Lab Med; 2002 Oct; 126(10):1243-4. PubMed ID: 12385333 [No Abstract] [Full Text] [Related]
87. Sudden ventricular fibrillation and death during ibrutinib therapy-A case report. Bernardeschi P; Pirrotta MT; Del Rosso A; Fontanelli G; Milandri C Eur J Haematol; 2019 Oct; 103(4):442-443. PubMed ID: 31287200 [TBL] [Abstract][Full Text] [Related]
88. Effective treatment of Bing-Neel Syndrome with oral fludarabine: a case series of four consecutive patients. Vos JM; Kersten MJ; Kraan W; Groeneveld ON; Linn C; Pals ST; Minnema MC Br J Haematol; 2016 Feb; 172(3):461-4. PubMed ID: 25944724 [No Abstract] [Full Text] [Related]
89. [Bing-Neel syndrome: Report of 4 cases and literature review]. Boudin L; Romeo E; Mavrovi E; Tsitsi Nding P; Blade JS; de Jaureguiberry JP; Gisserot O Rev Med Interne; 2015 Jun; 36(6):418-22. PubMed ID: 24907109 [TBL] [Abstract][Full Text] [Related]
90. Complete Response of a Young Woman With MYD88 Pabon CM; Neff JL; Forns TE; Wang J Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e809-e812. PubMed ID: 32660904 [No Abstract] [Full Text] [Related]
91. Evaluation and Management of Bing-Neel Syndrome. Schep SJ; Vos JMI; Minnema MC Hematol Oncol Clin North Am; 2023 Aug; 37(4):777-786. PubMed ID: 37258354 [TBL] [Abstract][Full Text] [Related]
92. The promising impact of ibrutinib, a Bruton's tyrosine kinase inhibitor, for the management of lymphoid malignancies. Bhatt V; Alejandro L; Michael A; Ganetsky A Pharmacotherapy; 2014 Mar; 34(3):303-14. PubMed ID: 24338680 [TBL] [Abstract][Full Text] [Related]
93. Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies-A single institution experience and a review of literature. Shaikh H; Khattab A; Faisal MS; Chilkulwar A; Albrethsen M; Sadashiv S; Fazal S J Oncol Pharm Pract; 2019 Jul; 25(5):1265-1270. PubMed ID: 30045682 [TBL] [Abstract][Full Text] [Related]
94. Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins. Ambinder AJ; Hambley B; Shanbhag S; Merrill SA Am J Hematol; 2019 Nov; 94(11):E296-E299. PubMed ID: 31400009 [No Abstract] [Full Text] [Related]
96. Ibrutinib in CLL/SLL: From bench to bedside (Review). Zi F; Yu L; Shi Q; Tang A; Cheng J Oncol Rep; 2019 Dec; 42(6):2213-2227. PubMed ID: 31638169 [TBL] [Abstract][Full Text] [Related]
97. Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies. Aw A; Brown JR Drugs Aging; 2017 Jul; 34(7):509-527. PubMed ID: 28536906 [TBL] [Abstract][Full Text] [Related]
98. A case of Bing-Neel syndrome presenting as spinal cord compression. Rigamonti A; Lauria G; Melzi P; Mantero V; Vismara D; Rossi G; Tetto A; Salmaggi A J Neurol Sci; 2014 Nov; 346(1-2):345-7. PubMed ID: 25201716 [No Abstract] [Full Text] [Related]
99. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Minnema MC; Kimby E; D'Sa S; Fornecker LM; Poulain S; Snijders TJ; Kastritis E; Kremer S; Fitsiori A; Simon L; Davi F; Lunn M; Castillo JJ; Patterson CJ; Le Garff-Tavernier M; Costopoulos M; Leblond V; Kersten MJ; Dimopoulos MA; Treon SP Haematologica; 2017 Jan; 102(1):43-51. PubMed ID: 27758817 [TBL] [Abstract][Full Text] [Related]
100. Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib. Cheng MP; Kusztos AE; Gustine JN; Dryden-Peterson SL; Dubeau TE; Woolley AE; Hammond SP; Baden LR; Treon SP; Castillo JJ; Issa NC Br J Haematol; 2019 May; 185(4):788-790. PubMed ID: 30460682 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]